Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas H Taylor

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Cancer|December 26, 2008
Survival of distinct Asian groups among colorectal cancer cases in CaliforniaHoa Le, Argyrios Ziogas, Thomas H Taylor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2011
Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003Lauri A Hicks, Yu-Wen Chien, Thomas H Taylor, et al.
Antimicrobial Resistance and Infection Control|December 2, 2016
Comparing the disk-diffusion and agar dilution tests for <i>Neisseria gonorrhoeae</i> antimicrobial susceptibility testingHsi Liu, Thomas H Taylor, Kevin Pettus, et al.
Journal of Carcinogenesis|April 13, 2011
Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysisKavitha P Raj, Thomas H Taylor, Charlie Wray, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 11, 2011
Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancerLeona Bessonova, Thomas H Taylor, Rita S Mehta, et al.
Current HIV Research|July 18, 2006
Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphomaCatherine Diamond, Thomas H Taylor, Theresa Im, et al.
Cancer Causes & Control : CCC|January 20, 2007
How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?Catherine Diamond, Thomas H Taylor, Theresa Im, et al.
Breast Cancer Research : BCR|February 21, 2009
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer RegistryJason A Zell, Walter Y Tsang, Thomas H Taylor, et al.
Pigment Cell & Melanoma Research|October 26, 2012
A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are importantFeng Liu, Leona Bessonova, Thomas H Taylor, et al.
The Laryngoscope|October 2, 2003
Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatmentWilliam B Armstrong, X Steven Wan, Ann R Kennedy, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Cancer|December 26, 2008
Survival of distinct Asian groups among colorectal cancer cases in CaliforniaHoa Le, Argyrios Ziogas, Thomas H Taylor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2011
Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003Lauri A Hicks, Yu-Wen Chien, Thomas H Taylor, et al.
Antimicrobial Resistance and Infection Control|December 2, 2016
Comparing the disk-diffusion and agar dilution tests for <i>Neisseria gonorrhoeae</i> antimicrobial susceptibility testingHsi Liu, Thomas H Taylor, Kevin Pettus, et al.
Journal of Carcinogenesis|April 13, 2011
Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysisKavitha P Raj, Thomas H Taylor, Charlie Wray, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 11, 2011
Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancerLeona Bessonova, Thomas H Taylor, Rita S Mehta, et al.
Current HIV Research|July 18, 2006
Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphomaCatherine Diamond, Thomas H Taylor, Theresa Im, et al.
Cancer Causes & Control : CCC|January 20, 2007
How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?Catherine Diamond, Thomas H Taylor, Theresa Im, et al.
Breast Cancer Research : BCR|February 21, 2009
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer RegistryJason A Zell, Walter Y Tsang, Thomas H Taylor, et al.
Pigment Cell & Melanoma Research|October 26, 2012
A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are importantFeng Liu, Leona Bessonova, Thomas H Taylor, et al.
The Laryngoscope|October 2, 2003
Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatmentWilliam B Armstrong, X Steven Wan, Ann R Kennedy, et al.
Pageof 8